Cargando…

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis

BACKGROUND: Human menopausal gonadotrophins and recombinant human follicle stimulating hormone are the two main gonadotrophin products utilized for controlled ovarian stimulation in assisted reproductive technologies. In this meta-analysis, the number of oocytes was designated as the most relevant e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehert, Philippe, Schertz, Joan C, Ezcurra, Diego
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954883/ https://www.ncbi.nlm.nih.gov/pubmed/20846363 http://dx.doi.org/10.1186/1477-7827-8-112

Ejemplares similares

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2014)

Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study
por: Strezsak, Valerie, et al.
Publicado: (2023)

In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review
por: Trew, Geoffrey H, et al.
Publicado: (2010)

The Human Oocyte Preservation Experience (HOPE) a phase IV, prospective, multicenter, observational oocyte cryopreservation registry
por: Ezcurra, Diego, et al.
Publicado: (2009)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
por: Wex, Jaro, et al.
Publicado: (2013)

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
por: Maghraby, Hassan Ali, et al.
Publicado: (2022)

Human Gonadotrophin Secretion
por: Franchimont, P.
Publicado: (1972)

Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
por: Hua, Rui, et al.
Publicado: (2013)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotrophin treatment
por: Hemmings, K.E., et al.
Publicado: (2013)

Low-dose human menopausal gonadotrophin versus natural cycles in intrauterine insemination for subfertile couples with regular menstruation
por: Li, Sichen, et al.
Publicado: (2020)

The average gonadotrophin dosage per follicle is predictive of ovarian response and cumulative live birth chances after in vitro fertilization: a retrospective cohort study
por: Liu, Shan, et al.
Publicado: (2023)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Enhancement of human chorionic gonadotrophin production by antimetabolites.
por: Browne, P., et al.
Publicado: (1982)

Follicle Stimulating Hormone and Anti-Müllerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study
por: Weghofer, Andrea, et al.
Publicado: (2012)

Ectopic Production of Human Chorionic Gonadotrophin by Human Breast Tumours
por: Sheth, N. A., et al.
Publicado: (1974)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
por: Yang, Chunxia, et al.
Publicado: (2022)

Human Chorionic Gonadotrophin: New Pleiotropic Functions for an “Old” Hormone During Pregnancy
por: Gridelet, Virginie, et al.
Publicado: (2020)

Meiotic Recombination in Human Oocytes
por: Cheng, Edith Y., et al.
Publicado: (2009)

The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
por: Rinaldi, Fabio, et al.
Publicado: (2023)

Effects of 17β-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women
por: Wide, Leif, et al.
Publicado: (2010)

In vitro follicle growth supports human oocyte meiotic maturation
por: Xiao, Shuo, et al.
Publicado: (2015)

Gonadotrophins: The future
por: Patil, Madhuri
Publicado: (2014)

STUDIES ON THE HUMAN OOCYTE AND ITS FOLLICLE : I. Ultrastructural and Histochemical Observations on the Primordial Follicle Stage
por: Hertig, Arthur T., et al.
Publicado: (1967)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Environment, human reproduction, menopause, and andropause.
por: Vermeulen, A
Publicado: (1993)

OVARIAN STEROID CELLS : I. Differentiation of the Lutein Cell from the Granulosa Follicle Cell during the Preovulatory Stage and under the Influence of Exogenous Gonadotrophins
por: Blanchette, E. Joan
Publicado: (1966)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
por: Ezcurra, Diego, et al.
Publicado: (2014)

In vitro secretion of human chorionic gonadotrophin by bladder tumour cells.
por: Iles, R. K., et al.
Publicado: (1987)

Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease
por: Walkington, L, et al.
Publicado: (2011)

Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2014)

Influence of human chorionic gonadotrophin during ovarian stimulation: an overview
por: Smitz, Johan, et al.
Publicado: (2020)

The expression of Beta Human Chorionic Gonadotrophin (β-HCG) in human urothelial carcinoma
por: Venyo, Anthony Kodzo-Grey, et al.
Publicado: (2010)

Oocyte formation by mitotically-active germ cells purified from ovaries of reproductive age women
por: White, Yvonne A. R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o153tcvm3aj0clokqrmufii4qg